• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型选择性广谱抗DNA病毒剂。

A novel selective broad-spectrum anti-DNA virus agent.

作者信息

De Clercq E, Holý A, Rosenberg I, Sakuma T, Balzarini J, Maudgal P C

出版信息

Nature. 1986;323(6087):464-7. doi: 10.1038/323464a0.

DOI:10.1038/323464a0
PMID:3762696
Abstract

A new compound has been found, (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine ((S)-HPMPA), that has potent and selective activity against a broad spectrum of DNA viruses, including herpes simplex virus (types 1 and 2); varicella zoster virus; thymidine kinase-deficient (TK-) mutants of herpes simplex and varicella zoster virus; human cytomegalovirus; phocid, simian, suid, bovid and equid herpesviruses; African swine fever virus; vaccinia virus; and human adenoviruses. It is also active against retroviruses. We also report that, in mice and rabbits in vivo, the compound is effective against both local and systemic infections with herpes simplex virus type 1, including herpetic keratitis caused by a TK- mutant which is resistant to the classical anti-herpes drugs.

摘要

已发现一种新化合物,即(S)-9-(3-羟基-2-膦酰甲氧基丙基)腺嘌呤((S)-HPMPA),它对多种DNA病毒具有强效且选择性的活性,包括单纯疱疹病毒(1型和2型);水痘带状疱疹病毒;单纯疱疹病毒和水痘带状疱疹病毒的胸苷激酶缺陷型(TK-)突变体;人巨细胞病毒;海豹、猿猴、猪、牛和马的疱疹病毒;非洲猪瘟病毒;痘苗病毒;以及人腺病毒。它对逆转录病毒也有活性。我们还报告称,在小鼠和兔子体内,该化合物对1型单纯疱疹病毒的局部和全身感染均有效,包括由对经典抗疱疹药物耐药的TK-突变体引起的疱疹性角膜炎。

相似文献

1
A novel selective broad-spectrum anti-DNA virus agent.一种新型选择性广谱抗DNA病毒剂。
Nature. 1986;323(6087):464-7. doi: 10.1038/323464a0.
2
Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.(S)-HPMPA对胸苷激酶缺陷型单纯疱疹病毒性角膜炎的疗效。
Invest Ophthalmol Vis Sci. 1987 Feb;28(2):243-8.
3
Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis.广谱抗DNA病毒药物(S)-9-(3-羟基-2-膦酰甲氧基丙基)腺嘌呤的细胞内磷酸化作用及对病毒DNA合成的抑制作用
Mol Pharmacol. 1987 Oct;32(4):524-9.
4
Selective virus inhibitors.选择性病毒抑制剂。
Microbiologica. 1990 Apr;13(2):165-78.
5
Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.病毒耐药性:单纯疱疹病毒胸苷激酶缺陷(TK-)突变体。治疗方法。
Ann Ist Super Sanita. 1987;23(4):841-7.
6
New acquisitions in the chemotherapy of viral infections.病毒感染化疗方面的新进展。
Verh K Acad Geneeskd Belg. 1990;52(1):69-99.
7
Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses.9-(S)-(3-羟基-2-膦酰甲氧基丙基)腺嘌呤的烷氧基烷基衍生物对巨细胞病毒和正痘病毒的合成及抗病毒评价
J Med Chem. 2006 Mar 23;49(6):2010-5. doi: 10.1021/jm050473m.
8
Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.腺嘌呤的膦酰基甲氧基烷基衍生物在体内实验性单纯疱疹病毒和痘苗病毒感染中的疗效。
Antimicrob Agents Chemother. 1989 Feb;33(2):185-91. doi: 10.1128/AAC.33.2.185.
9
(S)-9-(2,3-Dihydroxypropyl)adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity.(S)-9-(2,3-二羟基丙基)腺嘌呤:一种具有广谱抗病毒活性的脂肪族核苷类似物。
Science. 1978 May 5;200(4341).
10
Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines.嘌呤和嘧啶的膦酰甲氧基烷基衍生物的抗病毒活性。
Antiviral Res. 1987 Dec;8(5-6):261-72. doi: 10.1016/s0166-3542(87)80004-9.

引用本文的文献

1
A bibliometric analysis of Mpox research based on Web of Science platform.基于科学网平台的猴痘研究文献计量分析
Medicine (Baltimore). 2025 Jul 11;104(28):e43329. doi: 10.1097/MD.0000000000043329.
2
Treating Adenovirus Infection in Transplant Populations: Therapeutic Options Beyond Cidofovir?治疗移植人群中的腺病毒感染:除西多福韦之外的治疗选择?
Viruses. 2025 Apr 23;17(5):599. doi: 10.3390/v17050599.
3
Sixty Years at the Rega Institute.鲁汶大学雷加研究所的六十年
Viruses. 2025 Feb 5;17(2):222. doi: 10.3390/v17020222.
4
Molecularly Imprinted Polymeric Nanoparticles as Drug Delivery System for Tenofovir, an Acyclic Nucleoside Phosphonate Antiviral.分子印迹聚合物纳米颗粒作为替诺福韦(一种无环核苷膦酸抗病毒药物)的药物递送系统
Pharmaceutics. 2024 Jul 21;16(7):965. doi: 10.3390/pharmaceutics16070965.
5
Selected Milestones in Antiviral Drug Development.抗病毒药物研发的重要里程碑
Viruses. 2024 Jan 23;16(2):169. doi: 10.3390/v16020169.
6
Anti-herpes simplex virus activities and mechanisms of marine derived compounds.海洋来源化合物的抗单纯疱疹病毒活性及机制。
Front Cell Infect Microbiol. 2024 Jan 8;13:1302096. doi: 10.3389/fcimb.2023.1302096. eCollection 2023.
7
Cytomegalovirus in children undergoing haematopoietic stem cell transplantation: a diagnostic and therapeutic approach to antiviral resistance.接受造血干细胞移植儿童的巨细胞病毒感染:抗病毒耐药性的诊断与治疗方法
Front Pediatr. 2023 May 30;11:1180392. doi: 10.3389/fped.2023.1180392. eCollection 2023.
8
Hydrogen Bonding (Base Pairing) in Antiviral Activity.氢键(碱基配对)在抗病毒活性中的作用。
Viruses. 2023 May 10;15(5):1145. doi: 10.3390/v15051145.
9
Cidofovir for the Treatment of Molluscum Contagiosum Virus.西多福韦治疗传染性软疣病毒。
Viruses. 2022 Nov 10;14(11):2484. doi: 10.3390/v14112484.
10
Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation).雷吉奥医学研究协会五十周年纪念文集(雷吉奥协会 vzw,雷吉奥基金会)。
Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221129979. doi: 10.1177/20402066221129979.